Volume 143, Issue 2, Pages (August 2012)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 1, Pages e1 (January 2010)
Advertisements

Volume 136, Issue 5, Pages (May 2009)
Volume 134, Issue 7, Pages (June 2008)
Presentation, Diagnosis, and Management of Achalasia
Actions by Angiotensin II on Esophageal Contractility in Humans
Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia  Peter J. Kahrilas*,
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
An Alginate-Antacid Formulation Localizes to the Acid Pocket to Reduce Acid Reflux in Patients With Gastroesophageal Reflux Disease  Wout O. Rohof, Roel.
Achalasia: Update on the Disease and Its Treatment
Volume 126, Issue 1, Pages (January 2004)
Obesity: A Challenge to Esophagogastric Junction Integrity
Srdjan V. Kostic, MDa, Thomas W. Rice, MDa, Mark E
Covering the Cover Gastroenterology
Outcomes Among Living Liver Donors
Volume 144, Issue 4, Pages e17-e18 (April 2013)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 59, Issue 1, Pages (January 2001)
Volume 149, Issue 2, Pages (August 2015)
David J. Brenner, Eric J. Hall, Rochelle E. Curtis, Elaine Ron 
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Covering the Cover Gastroenterology
Volume 133, Issue 3, Pages (September 2007)
Volume 135, Issue 5, Pages (November 2008)
Clinical Challenges and Images in GI
Volume 134, Issue 7, Pages (June 2008)
Volume 150, Issue 4, Pages (April 2016)
Volume 149, Issue 2, Pages (August 2015)
Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B  Jeong Han Kim, So Young Kwon, Young Sok.
Probiotics in Perspective
Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia
Functional Dyspepsia Is Associated With Sleep Disorders
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Peter J. Kahrilas, Guy Boeckxstaens  Gastroenterology 
Update on the Use of Vonoprazan: A Competitive Acid Blocker
The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus  Andrea Shin, Michael.
Volume 141, Issue 4, Pages e3 (October 2011)
Effects of Age on the Gastroesophageal Junction, Esophageal Motility, and Reflux Disease  Jacqueline Lee, Angela Anggiansah, Roy Anggiansah, Alasdair.
Volume 138, Issue 1, Pages (January 2010)
Volume 138, Issue 1, Pages e1 (January 2010)
Challenging the Limits of Esophageal Manometry
A Comparison of Symptom Severity and Bolus Retention With Chicago Classification Esophageal Pressure Topography Metrics in Patients With Achalasia  Frédéric.
How to Effectively Use High-Resolution Esophageal Manometry
Volume 139, Issue 2, Pages (August 2010)
Expression Quantitative Trait Loci Analysis Identifies Associations Between Genotype and Gene Expression in Human Intestine  Boyko Kabakchiev, Mark S.
Esophageal Diameter Is Decreased in Some Patients With Eosinophilic Esophagitis and Might Increase With Topical Corticosteroid Therapy  Joohee Lee, James.
Rafael Esteban, Maria Buti  Gastroenterology 
David H. Bruining, William J. Sandborn 
Normal Values of Esophageal Distensibility and Distension-Induced Contractility Measured by Functional Luminal Imaging Probe Panometry  Dustin A. Carlson,
A Selection of the Best AGA Abstracts of DDW 2017
Volume 133, Issue 2, Pages (August 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 135, Issue 1, Pages (July 2008)
Covering the Cover Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Advances in Management of Esophageal Motility Disorders
Volume 140, Issue 6, Pages e2 (May 2011)
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double.
Volume 156, Issue 1, Pages 7-10 (January 2019)
Volume 131, Issue 6, Pages (December 2006)
Michelle Maria Pietzak  Gastroenterology 
Volume 139, Issue 6, Pages e1 (December 2010)
Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn’s Disease: Captivating Pathology, Hybrid Therapy  Long Le, Brian M. Fung, James H. Tabibian 
Volume 138, Issue 6, Pages (May 2010)
Volume 136, Issue 5, Pages (May 2009)
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
Achalasia: Update on the Disease and Its Treatment
Volume 151, Issue 2, Pages (August 2016)
Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus
Presentation transcript:

Volume 143, Issue 2, Pages 328-335 (August 2012) Efficacy of Treatment for Patients With Achalasia Depends on the Distensibility of the Esophagogastric Junction  Wout O. Rohof, David P. Hirsch, Boudewijn F. Kessing, Guy E. Boeckxstaens  Gastroenterology  Volume 143, Issue 2, Pages 328-335 (August 2012) DOI: 10.1053/j.gastro.2012.04.048 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 A flowchart describes the patient groups in the study. Seven patients were studied before and after initial treatment. Thirty patients were studied after therapy; 18 were treated successfully (Eckardt score <4), and 12 were treated unsuccessfully. Eight of 12 unsuccessfully treated patients were additionally treated; 5 of these patients underwent an additional EndoFLIP measurement. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 The EGJ opening is plotted against the intrabag pressure in A for healthy volunteers (n = 15), patients with successful treatment (n = 18), patients with failed to respond to treatment (n = 12), and newly diagnosed patients (n = 7). Starting from a 40-mL volumetric distention, patients who failed to respond to treatment had a clearly smaller EGJ opening at higher intrabag pressure, corresponding with a significantly lower distensibility compared with successfully treated patients and healthy volunteers. Newly diagnosed patients clearly had the most impaired EGJ distensibility. B shows the separate measurements of the included groups at the maximal volumetric distention of 50 mL. The 90th percentile of EGJ distensibility of healthy volunteers is marked. Open symbols are used in case values are below the 90th percentile. Of the successfully treated patients, 78% were above the 90th percentile of healthy volunteers, in contrast to only 8% and 0% of patients who failed to respond to treatment and newly diagnosed patients, respectively. ***P < .001, **P < .01, *P < .05. Tests were performed with a Student t test with Bonferroni correction. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Examples of EndoFLIP measurement during volumetric distentions in (A) a healthy volunteer, (B) a patient with successful treatment, (C) a patient with recurrent symptoms, and (D) a patient before initial treatment are depicted. The bag has a cylindrical shape, of which the varying diameter corresponds with the opening at that point, and the exact values can be observed in the right panel of each measurement. The narrowest diameter corresponds with the EGJ opening. The EGJ opening is clearly wider in the healthy volunteer and the patient with treatment success compared with the patient with treatment failure and the newly diagnosed patient. Additionally, bag pressures are lower in treatment success, indicating that less pressure is needed to open the EGJ, corresponding with a higher distensibility. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 The effect of initial treatment is depicted (n = 7), showing increased distensibility at the different volumetric distentions after treatment in A, which is statistically significant at the largest volumetric distention (*P < .05; Wilcoxon signed rank test). Additionally, B and C show that the effect of treatment on distensibility differs and that an increase correlates excellently with the decrease in symptoms (r = 0.89; P < .01; Spearman rank correlation). The 3 patients marked with an open symbol in B and C have an impaired distensibility after therapy (<2.9 mm2/mm Hg). All 3 patients needed additional therapy due to persistent symptoms. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 Values for (A) EGJ distensibility, (B) LES pressure, and (C) esophageal stasis are compared for successfully treated patients (n = 18) and patients who failed to respond to treatment (n = 12). Distensibility and LES pressure are higher in successfully treated patients, whereas the height of esophageal stasis 5 minutes after barium ingestion is lower in successfully treated patients compared with patients who failed to respond to treatment. Although there are significant differences, the discriminatory value of the cutoffs (marked by a dotted line) differs among the 3 parameters. Open symbols are used in case values are less than (EGJ distensibility) or greater than (LES pressure and esophageal stasis) the cutoff value. Of patients who failed to respond to treatment, 92% and 89% had impaired EGJ distensibility and impaired esophageal emptying, respectively, whereas 42% had elevated LES pressure. **P < .01, *P < .05; Student t test. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 The height of the barium column is plotted at the different measurement times for patients with a normal distensibility (n = 10), and for patients with an impaired distensibility (n = 14). Right after ingestion, there is no difference in column height. The height of the barium column is significantly lower after 1, 2, and 5 minutes in patients with a normal distensibility, corresponding with a significantly better esophageal emptying. *P < .05, **P < .01; Student t test. Gastroenterology 2012 143, 328-335DOI: (10.1053/j.gastro.2012.04.048) Copyright © 2012 AGA Institute Terms and Conditions